The deal priced below last closing price of $2.86. ThinkEquity is acting as sole book running manager for the offering.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 55% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See the top stocks recommended by analysts >>
Read More on CVM:
- Cel-Sci (NYSE:CVM) Plummets on $5M Stock Offering
- CEL-SCI announces common stock offering, no amount given
- CEL-SCI concludes provides update on Multikine immunotherapy path to market
- CEL-SCI: Multikine can be effective in extending life for head & neck cancer
- CEL-SCI to present data from Phase 3 study in SCCHN at AHNS Conference